Bud BilanichSuccess Coach
Frank BurrellScientific Storytelling
Liz KaneImpactful Strategy
Paul TheisenPatient Acquisition
Pat PurcellMeeting Engagement
Matthew DurhamOmnidynamic Marketing
Daniel SontupeMarket Access
Joey CohenMedication Adherence
David LinetskyPoint-of-Care Marketing
Matt TurnerPatient Affordability
Stacey GandlerBrand Nourishment
Amy GilesIncreasing Engagement
Suma Ramadas, PhDMedical Affairs
Brenda SnowAuthentic Patient Voice
ZEJULA is the first PARP inhibitor approved in Europe for women with recurrent ovarian ...
NEW YORK, Feb. 02, 2018 (GLOBE NEWSWIRE) -- via NetworkWire — NetworkNewsWire ("NNW"), a ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email